Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
Official title: The Effect of Erector Spinae Block Versus Paravertebral Block on the Incidence of Chronic Pain After Mastectomy: A Randomized Controlled Trial
Run by American University of Beirut Medical Center · NCT07561411 · Data updated 2026-11-12
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | American University of Beirut Medical Center Academic / other |
| Locations | 1 site (Beirut) |
| Status | Recruiting |
| Started | May 19, 2026 |
| Main results expected | May 1, 2028 |
| Study ends | May 1, 2028 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT07561411 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 undergoing total mastectomy (with or without axillary dissection), ASA 1–3, eligible for regional anesthesia in addition to general anesthesia.
✕Probably not a fit
Patients with contraindications to regional blocks, chronic pain or severe depression, ASA 4+, or those not receiving regional anesthesia may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, interventional trial compares two regional anesthesia techniques—erector spinae block and paravertebral block—in adults undergoing total mastectomy with or without axillary dissection. The study seeks to determine if the erector spinae block lowers the incidence of chronic pain at 3 months and influences perioperative outcomes such as opioid use, early pain scores, block performance time, and short-term complications or mood symptoms. Enrollment targets 132 participants (66 per group) at the American University of Beirut Medical Center. Participants are adults aged 18–80, ASA 1–3, scheduled for mastectomy and willing to receive regional anesthesia in addition to general anesthesia. Exclusion criteria include prior thoracic surgery with large incisions, allergy to local anesthetics, pregnancy, significant coagulopathy, ASA 4+, or history of chronic pain or untreated depression.
Why it matters
Potential benefit: If successful, patients may experience less chronic pain after mastectomy and lower perioperative opioid needs.
How similar studies have gone: Prior evidence suggests regional blocks can reduce acute/postoperative pain; this study tests equivalence or superiority of ESB versus PVB for chronic pain outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients between 18 and 80 years old. * Scheduled to total mastectomy with or without axillary dissection * Willing to receive regional anesthesia in addition to GA * ASA classification 1-3 Exclusion Criteria: * Previous thoracic surgery with an incision of \>2 cm * Patient's refusal * Allergy to local anesthetics * Pregnant women * Any contraindications to thoracic PVB, including intrathoracic infection, infection at the puncture site, cancer invasion of the puncture site, severe spinal deformity, history of spinal surgery, and severe coagulopathy; anticoagulants intake. * American Society of Anesthesiologists (ASA) classification of 4 or higher, * History of chronic pain or untreated clinical severe depression
Where it's running
-
American University of Beirut Medical Center
Beirut, Lebanon Recruiting
Study contacts
- Principal investigator: Nancy Abou Nafeh, MD — American University of Beirut Medical Center
- Study coordinator: Nancy Abou Nafeh, MD
- Email: na181@aub.edu.lb
- Phone: 01350000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pectoral nerve block versus thoracic paravertebral block to prevent chronic pain after mastectomy
This trial will test whether a pectoral (PECS) block or a thoracic paravertebral (TPVB) block given during mastectomy better prevents long-term chest, axillary, or arm pain in adult women.
-
Pharmacist-led opioid stewardship for adults with chronic non-cancer pain
This program will test whether a pharmacist-led opioid stewardship program helps adults with chronic non-cancer pain reduce high-risk opioid prescriptions and improve their knowledge and attitudes about opioid use.
-
Comparing dexmedetomidine and lidocaine for pain management after mastectomy
This study is testing whether dexmedetomidine or lidocaine works better for managing pain after mastectomy surgery in adults aged 18 to 75.
-
Comparing two nerve-block options to reduce pain after total mastectomy.
This test tries whether a PECS-II block given before surgery or a pectoral block given during surgery, using bupivacaine or liposomal bupivacaine, provides better pain control after total mastectomy for breast cancer or high-risk patients.
-
Bionic breast implant to restore touch and reduce chronic pain after mastectomy
This project will try a bionic breast implant that stimulates nerves to restore touch and reduce chronic pain for adults having bilateral mastectomy with two-stage (tissue expander) reconstruction.
-
Improving sleep and reducing opioid use in people with chronic pain
This study is testing if a sleep therapy can help people with chronic pain sleep better and use fewer opioids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.